From ADCs, PROTACs and TIDES to highly potent APls, Veranova has the expertise to tackle your toughest development challenges

At Veranova, our extensive experience in specialized and complex API development enables the delivery of customized solutions across a wide range of specialty modalities. Spanning research and development to commercial-scale GMP production, our capabilities cover key areas:

ADC Molecule

[White Paper] Comprehensive Analytical Techniques for ADCs

TIDES molecule

[Expert Insights] The Growth of Peptide and Oligonucleotide Therapeutics

We are building the CDMO for pharma’s advanced molecules, so that you can create the therapeutics of next generation with confidence.

With significant investments to expand our ADC and highly potent API capabilities and further strategic investment to establish cGMP bioconjugation capability in our state of the art facility in Devens, MA, we’re the team to tackle your toughest development challenges

Where complexity is turned into opportunity

With 19 years of experience in handling multi-ADC linker-payload systems, Veranova has the expertise to manage your complex ADC projects with confidence

 

Learn more about our ADC capabilities in our latest whitepaper

De-risk ADC scale-up: the executive guide to audit-ready analytics

ADC programs don’t fail on promise, they slip on analytics. Our whitepapers give you a practical, lab-to-plant playbook to:

  • Control DAR and its distribution
  • Purge free payload
  • Align method lifecycle
  • Achieve audit-ready analytics

Our Specialty Modality Services

Veranova is your next great decision

Discover new ways to advance your science with Veranova.

Contact us